Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate COMPASS Pathways plc before investing.

In this article, we go over a few key elements for understanding COMPASS Pathways plc’s stock price such as:

• COMPASS Pathways plc’s current stock price and volume
• Why COMPASS Pathways plc’s stock price changed recently
• Upgrades and downgrades for CMPS from analysts
• CMPS’s stock price momentum as measured by its relative strength

About COMPASS Pathways plc (CMPS)

Before we jump into COMPASS Pathways plc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Want to learn more about COMPASS Pathways plc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about COMPASS Pathways plc.

COMPASS Pathways plc’s Stock Price as of Market Close

As of February 19, 2026, 4:00 PM, CST, COMPASS Pathways plc’s stock price was $8.260.

COMPASS Pathways plc is down 2.25% from its previous closing price of $8.450.

During the last market session, COMPASS Pathways plc’s stock traded between $7.710 and $8.520. Currently, there are approximately 95.34 million shares outstanding for COMPASS Pathways plc.

COMPASS Pathways plc’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

COMPASS Pathways plc Stock Price History

COMPASS Pathways plc’s (CMPS) price is currently up 23.47% so far this month.

During the month of February, COMPASS Pathways plc’s stock price has reached a high of $8.900 and a low of $5.665.

Over the last year, COMPASS Pathways plc has hit prices as high as $8.900 and as low as $2.250. Year to date, COMPASS Pathways plc’s stock is up 19.71%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused COMPASS Pathways plc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 19, 2026, there were 0 analysts who downgraded COMPASS Pathways plc’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate COMPASS Pathways plc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on COMPASS Pathways plc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about COMPASS Pathways plc (CMPS) by visiting AAII Stock Evaluator.

Relative Price Strength of COMPASS Pathways plc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 19, 2026, COMPASS Pathways plc has a weighted four-quarter relative price strength of 22.31%, which translates to a Momentum Score of 90 and is considered to be Very Strong.

Want to learn more about how COMPASS Pathways plc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

COMPASS Pathways plc Stock Price: Bottom Line

As of February 19, 2026, COMPASS Pathways plc’s stock price is $8.260, which is down 2.25% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like COMPASS Pathways plc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.